Plus Therapeutics | CYTX - Selling And Administration Expenses

Stock Price
6.60
Daily Change
-0.68 -9.34%
Monthly
7.36%
Yearly
-66.49%
Q2 Forecast
6.46

Plus Therapeutics reported $3.49M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
Baxter International USD 761M 53M Dec/2025
Cerus USD 19.33M 1.55M Dec/2024
Dr.Reddys Laboratories INR 26.92B 482M Dec/2025
Haemonetics USD 109.15M 7.54M Dec/2025
Infinity Pharmaceuticals USD 3.75M 2.19M Jun/2023
Northwest Biotherapeutics USD 7.07M 1.06M Sep/2025
Plus Therapeutics USD 3.49M 559K Dec/2025
Sanofi EUR 2.33B 419M Mar/2026
Starpharma Holdings AUD 4.42M 2.86M Dec/2025
Sun Pharmaceuticals INR 24.89B 637.6M Mar/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025